• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏和尿蛋白质组学的生物信息学:呼唤扩充。

Bioinformatics for Renal and Urinary Proteomics: Call for Aggrandization.

机构信息

St. Jude Childrens Cancer Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.

Department of Microbiology and Immunology, Institute for Biomedicine, Gothenburg University, 413 90 Gothenburg, Sweden.

出版信息

Int J Mol Sci. 2020 Jan 31;21(3):961. doi: 10.3390/ijms21030961.

DOI:10.3390/ijms21030961
PMID:32024005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7038205/
Abstract

The clinical sampling of urine is noninvasive and unrestricted, whereby huge volumes can be easily obtained. This makes urine a valuable resource for the diagnoses of diseases. Urinary and renal proteomics have resulted in considerable progress in kidney-based disease diagnosis through biomarker discovery and treatment. This review summarizes the bioinformatics tools available for this area of proteomics and the milestones reached using these tools in clinical research. The scant research publications and the even more limited bioinformatic tool options available for urinary and renal proteomics are highlighted in this review. The need for more attention and input from bioinformaticians is highlighted, so that progressive achievements and releases can be made. With just a handful of existing tools for renal and urinary proteomic research available, this review identifies a gap worth targeting by protein chemists and bioinformaticians. The probable causes for the lack of enthusiasm in this area are also speculated upon in this review. This is the first review that consolidates the bioinformatics applications specifically for renal and urinary proteomics.

摘要

临床尿液采样具有非侵入性和无限制的特点,因此可以轻松获得大量尿液样本。这使得尿液成为疾病诊断的宝贵资源。尿液和肾脏蛋白质组学通过生物标志物的发现和治疗,在肾脏疾病诊断方面取得了相当大的进展。本综述总结了该蛋白质组学领域可用的生物信息学工具,以及使用这些工具在临床研究中取得的里程碑式进展。本综述强调了尿液和肾脏蛋白质组学研究中可用的研究出版物和生物信息学工具选择非常有限的问题。强调需要更多的生物信息学家的关注和投入,以取得不断的进展和发布。现有的用于肾脏和尿液蛋白质组学研究的工具寥寥无几,本综述确定了蛋白质化学家与生物信息学家值得关注的一个目标领域。本综述还推测了该领域缺乏积极性的可能原因。这是第一篇专门针对肾脏和尿液蛋白质组学的生物信息学应用综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7038205/45658a1f821a/ijms-21-00961-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7038205/9c67a4aa2db9/ijms-21-00961-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7038205/c9b038787192/ijms-21-00961-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7038205/45658a1f821a/ijms-21-00961-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7038205/9c67a4aa2db9/ijms-21-00961-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7038205/c9b038787192/ijms-21-00961-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7038205/45658a1f821a/ijms-21-00961-g003.jpg

相似文献

1
Bioinformatics for Renal and Urinary Proteomics: Call for Aggrandization.肾脏和尿蛋白质组学的生物信息学:呼唤扩充。
Int J Mol Sci. 2020 Jan 31;21(3):961. doi: 10.3390/ijms21030961.
2
Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases.用于监测膀胱健康和泌尿系统疾病的尿液蛋白质组学和代谢组学研究。
BMC Urol. 2016 Mar 22;16:11. doi: 10.1186/s12894-016-0129-7.
3
Progress in understanding primary glomerular disease: insights from urinary proteomics and in-depth analyses of potential biomarkers based on bioinformatics.原发性肾小球疾病研究进展:基于生物信息学的尿液蛋白质组学和潜在生物标志物的深入分析。
Crit Rev Clin Lab Sci. 2023 Aug;60(5):346-365. doi: 10.1080/10408363.2023.2178378. Epub 2023 Feb 23.
4
A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database.尿液蛋白质组生物标志物发现的工具:一个人工整理的人类和动物尿液蛋白质生物标志物数据库。
Mol Cell Proteomics. 2011 Nov;10(11):M111.010975. doi: 10.1074/mcp.M111.010975. Epub 2011 Aug 29.
5
[Urinary proteomics: the diagnostic key for urinary tract abnormalities and kidney diseases in children?].[尿液蛋白质组学:儿童尿路异常和肾脏疾病的诊断关键?]
Urologe A. 2011 Feb;50(2):170-9. doi: 10.1007/s00120-010-2467-5.
6
Diagnostic potential for urinary proteomics.尿液蛋白质组学的诊断潜力。
Pharmacogenomics. 2007 Mar;8(3):237-55. doi: 10.2217/14622416.8.3.237.
7
Urinary exosomes and proteomics.尿外泌体与蛋白质组学。
Mass Spectrom Rev. 2011 Nov-Dec;30(6):1185-202. doi: 10.1002/mas.20319. Epub 2011 May 4.
8
Urinary proteomics--a tool for biomarker discovery.尿蛋白质组学——生物标志物发现的工具。
Ren Fail. 2010 Jan;32(2):259-68. doi: 10.3109/08860221003599759.
9
The non-invasive biopsy--will urinary proteomics make the renal tissue biopsy redundant?非侵入性活检——尿蛋白质组学是否会使肾组织活检变得多余?
QJM. 2009 Aug;102(8):523-38. doi: 10.1093/qjmed/hcp071. Epub 2009 Jun 24.
10
Advances in urinary proteome analysis and biomarker discovery.尿液蛋白质组分析及生物标志物发现的进展
J Am Soc Nephrol. 2007 Apr;18(4):1057-71. doi: 10.1681/ASN.2006090956. Epub 2007 Feb 28.

引用本文的文献

1
Development and Validation of a Non-Invasive Prediction Model for Glioma-Associated Epilepsy: A Comparative Analysis of Nomogram and Decision Tree.胶质瘤相关性癫痫非侵入性预测模型的开发与验证:列线图与决策树的比较分析
Int J Gen Med. 2025 Feb 26;18:1111-1125. doi: 10.2147/IJGM.S512814. eCollection 2025.
2
Expression analysis of human glioma susceptibility gene and in human glioma and its clinical significance based on bioinformatics.基于生物信息学的人类胶质瘤易感基因在人胶质瘤中的表达分析及其临床意义
Ann Transl Med. 2023 Jan 31;11(2):53. doi: 10.21037/atm-22-5646.
3
The potential mechanisms of neuroblastoma in children based on bioinformatics big data.

本文引用的文献

1
Protein Data Bank: the single global archive for 3D macromolecular structure data.蛋白质数据库:用于存储大分子三维结构数据的全球单一档案库。
Nucleic Acids Res. 2019 Jan 8;47(D1):D520-D528. doi: 10.1093/nar/gky949.
2
Exploring the Therapeutic Mechanism of on Oxalate Crystal-Induced Kidney Injuries Using Comprehensive Approaches Based on Proteomics and Network Pharmacology.基于蛋白质组学和网络药理学的综合方法探索[具体药物名称]对草酸盐晶体诱导的肾损伤的治疗机制
Front Pharmacol. 2018 Jun 13;9:620. doi: 10.3389/fphar.2018.00620. eCollection 2018.
3
Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy.
基于生物信息学大数据的儿童神经母细胞瘤潜在机制
Transl Pediatr. 2022 Dec;11(12):1908-1919. doi: 10.21037/tp-22-504.
尿蛋白质组分析鉴定出参与糖尿病肾病的 Neprilysin 和 VCAM 作为蛋白质。
J Diabetes Res. 2018 Apr 29;2018:6165303. doi: 10.1155/2018/6165303. eCollection 2018.
4
PDBsum: Structural summaries of PDB entries.PDBsum:蛋白质数据库(PDB)条目的结构摘要。
Protein Sci. 2018 Jan;27(1):129-134. doi: 10.1002/pro.3289. Epub 2017 Oct 27.
5
A comprehensive analysis and annotation of human normal urinary proteome.全面分析和注释人类正常尿蛋白质组。
Sci Rep. 2017 Jun 8;7(1):3024. doi: 10.1038/s41598-017-03226-6.
6
PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database.PharmMapper 2017 更新:一个带有全面药物靶点药效数据库的潜在药物靶点识别网络服务器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W356-W360. doi: 10.1093/nar/gkx374.
7
Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics.利用尿液蛋白质组学和生物信息学深入了解糖尿病肾病
J Am Soc Nephrol. 2017 Apr;28(4):1050-1061. doi: 10.1681/ASN.2016091018. Epub 2017 Feb 3.
8
Protein Bioinformatics Databases and Resources.蛋白质生物信息学数据库与资源
Methods Mol Biol. 2017;1558:3-39. doi: 10.1007/978-1-4939-6783-4_1.
9
Sparse network modeling and metscape-based visualization methods for the analysis of large-scale metabolomics data.用于大规模代谢组学数据分析的稀疏网络建模和基于Metscape的可视化方法。
Bioinformatics. 2017 May 15;33(10):1545-1553. doi: 10.1093/bioinformatics/btx012.
10
Untargeted Metabolomics Strategies-Challenges and Emerging Directions.非靶向代谢组学策略——挑战与新兴方向。
J Am Soc Mass Spectrom. 2016 Dec;27(12):1897-1905. doi: 10.1007/s13361-016-1469-y. Epub 2016 Sep 13.